Alternative Pathway Complement Activation and Low Circulating Inhibitors Associate With Severity and Mortality in COVID-19 and Non-COVID Sepsis
A103. DYSREGULATED PATHWAYS IN SEPSIS AND LUNG INJURY: SEARCHING FOR TREATABLE TRAITS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A2830-A2830
10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2830